Raymond James Financial Services Advisors, Inc. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$576,442
-26.6%
21,453
-2.6%
0.00%0.0%
Q2 2023$785,625
+87.2%
22,031
+33.4%
0.00%0.0%
Q1 2023$419,633
-43.7%
16,521
-10.1%
0.00%0.0%
Q4 2022$744,966
+16.2%
18,367
-5.2%
0.00%0.0%
Q3 2022$641,000
-3.6%
19,382
+2.7%
0.00%0.0%
Q2 2022$665,000
-77.8%
18,876
-71.0%
0.00%
-83.3%
Q1 2022$2,995,000
+28.1%
65,132
+84.7%
0.01%
+50.0%
Q4 2021$2,338,000
+16.4%
35,269
+9.6%
0.00%0.0%
Q3 2021$2,009,000
+1.9%
32,186
+35.2%
0.00%0.0%
Q2 2021$1,972,000
+53.9%
23,813
+23.3%
0.00%
+33.3%
Q1 2021$1,281,000
-18.9%
19,312
-6.2%
0.00%
-25.0%
Q4 2020$1,580,000
+22.2%
20,587
-31.4%
0.00%0.0%
Q3 2020$1,293,000
-12.8%
30,027
-12.5%
0.00%
-20.0%
Q2 2020$1,483,000
+39.0%
34,335
-7.5%
0.01%0.0%
Q1 2020$1,067,000
-58.1%
37,104
-7.5%
0.01%
-37.5%
Q4 2019$2,544,000
+208.0%
40,107
+36.9%
0.01%
+166.7%
Q3 2019$826,000
+895.2%
29,298
+154.1%
0.00%
Q1 2018$83,00011,5320.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders